Core Concepts
Dickkopf-2 (DKK2) is essential for the generation of colon cancer cells exhibiting Paneth cell properties, which form a cancer stem cell niche to facilitate metastatic tumor growth.
Abstract
The content explores the role of Dickkopf-2 (DKK2) in the development of colon cancer metastasis. Key highlights:
Splenic injection of Dkk2-knockout (KO) colon cancer organoids into mice resulted in significantly reduced liver metastases compared to control organoids.
Transcriptome analysis showed a reduction of Paneth cell markers, such as lysozymes, in the Dkk2 KO organoids.
Single-cell RNA sequencing of murine and human metastatic colon cancer samples identified the presence of lysozyme-positive (LYZ+) cancer cells with Paneth cell properties, including enhanced glycolysis.
Mechanistically, DKK2 promotes the generation of LYZ+ cancer cells with Paneth cell characteristics by reducing the HNF4α1 protein level, which in turn enhances the expression of the Paneth cell transcription factor Sox9.
The loss of LYZ+ cancer cells with Paneth cell properties in Dkk2 KO organoids and metastatic tumors resulted in reduced glycolysis and impaired metastatic growth, suggesting the importance of these cells in forming a cancer stem cell niche.
Overall, the findings demonstrate that DKK2-mediated generation of colon cancer cells with Paneth cell properties is essential for the development of metastases.
Stats
Dkk2 knockout significantly reduced the percentage of lysozyme-positive (LYZ+) cancer cells in liver metastatic tumors compared to control.
The percentile of LYZ+ cells in total cancer cells was decreased about 3-fold in Dkk2 knockout metastasized cells compared to the control.
Quotes
"DKK2 is indispensable for the generation of LYZ+ cancer cells in liver metastasized nodules by reducing protein levels of HNF4α1."
"DKK2-driven loss of HNF4α1 protein enhances Sox9 expression in colon cancer cells to generate LYZ+ cells with Paneth cell properties."